News
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...
In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg ...
Color additives have faced increased scrutiny since the FDA banned Red Dye No. 3, citing concerns over its links to cancer.
Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...
The Supreme Court backed the FDA's refusal to authorize the sale of kid-friendly flavored vapes, including the flavors ...
Inebilizumab-cdon was previously approved by the FDA for neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...
The U.S. Supreme Court on Wednesday largely backed the U.S. Food and Drug Administration's refusal to let two e-cigarette ...
A newly approved antibiotic to treat urinary tract infections, gepotidacin, also may help fight drug-resistant gonorrhea, a new study shows.
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
The U.S. Supreme Court upheld a series of decisions by the U.S. Food and Drug Administration to keep flavored vaping products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results